These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32394833)

  • 21. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
    Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
    Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticles and Their Applications in Lipid Signaling.
    Ashin ZF; Yacoub AS; Saady M; Thompson SE; Awad K; Aswath P; Brotto M; Varanasi V
    Methods Mol Biol; 2024; 2816():41-52. PubMed ID: 38977587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
    Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical and biomedical applications of lipid-based nanocarriers.
    Carbone C; Leonardi A; Cupri S; Puglisi G; Pignatello R
    Pharm Pat Anal; 2014 Mar; 3(2):199-215. PubMed ID: 24588596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.
    Gajbhiye KR; Salve R; Narwade M; Sheikh A; Kesharwani P; Gajbhiye V
    Mol Cancer; 2023 Oct; 22(1):160. PubMed ID: 37784179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
    Soica C; Coricovac D; Dehelean C; Pinzaru I; Mioc M; Danciu C; Fulias A; Puiu M; Sitaru C
    Recent Pat Nanotechnol; 2016; 10(2):128-45. PubMed ID: 27502390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate anchored lipid nanoparticles.
    Kakade P; Chatterjee A; Pandya A; Disouza J; Patravale V
    Int J Pharm; 2022 Apr; 618():121681. PubMed ID: 35307469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
    Rajpoot K
    Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
    Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
    Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-drug delivery system for the treatment of acute myelogenous leukemia.
    Zhang S; Sun J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications.
    Jose C; Amra K; Bhavsar C; Momin M; Omri A
    Crit Rev Ther Drug Carrier Syst; 2018; 35(6):555-588. PubMed ID: 30317969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers.
    Yaghmur A; Østergaard J; Mu H
    Adv Drug Deliv Rev; 2023 Dec; 203():115136. PubMed ID: 37944644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in Hybrid Vesicular-based Drug Delivery Systems: Improved Biocompatibility, Targeting, Therapeutic Efficacy and Pharmacokinetics of Anticancer Drugs.
    Setia A; Sahu RK; Ray S; Widyowati R; Ekasari W; Saraf S
    Curr Drug Metab; 2022; 23(9):757-780. PubMed ID: 35761494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-based Nanocarriers for Cancer and Tumor Treatment.
    Ansari MT; Ramlan TA; Jamaluddin NN; Zamri N; Salfi R; Khan A; Sami F; Majeed S; Hasnain MS
    Curr Pharm Des; 2020; 26(34):4272-4276. PubMed ID: 32693760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
    Sala M; Diab R; Elaissari A; Fessi H
    Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.